Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Novo submitted the drug to the US FDA in December 2025 based on the REDEFINE-1 and REDEFINE-2 trials
Stomach and gut side effects Stomach and gut symptoms are the most common reason people stop or struggle with retatrutide
Type 2 Diabetes Control: Used to improve blood sugar levels in adults with type 2 diabetes mellitus as an adjunct to diet and exercise
Glucagon activation increases energy expenditure and fat oxidation, adding a calorie-burning mechanism on top of the appetite suppression delivered by GLP-1 and GIP agonism
Major insurers increasingly recognize that covering obesity medication can reduce claims for related conditions including diabetes, heart disease, and joint problems
Why Choose Living Young Center
US$ 26.07
US$ 25.69
US$ 22.79
US$ 26.59
